Illumina (ILMN) Operating Margin (2009 - 2026)
Illumina's (ILMN) quarterly Operating Margin came in at 21.14% in Q2 2026, up 93.0% on a YoY basis from 10.95% in Q2 2025, and up 10.35% quarter-over-quarter from 19.16% in Q1 2026.
Powered by 
Analysis
Illumina (ILMN) Operating Margin (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported Operating Margin for 18 consecutive years, with 21.14% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Margin rose 93.0% year-over-year to 21.14%; the trailing twelve-month figure through Jun 2026 stood at 19.63% (down 1057.0% YoY), and the FY2025 full-year result was 18.58%, up 3763.0% from the prior year.
- Operating Margin grew to 21.14% in Q2 2026 per ILMN's latest filing, from 19.16% in the prior quarter.
- Across five years, Operating Margin topped out at 68.61% in Q3 2024 and bottomed at 327.98% in Q4 2022.
- Historically, Operating Margin has averaged 40.89% across 5 years, with a median of 4.58% in 2022.
- The sharpest annual moves came in 2022 and 2023: Operating Margin sank 27879 bps in 2022, then surged 30479 bps in 2023.
- Over 5 years, Operating Margin stood at 327.98% in 2022, then soared by 96 bps to 14.62% in 2023, then surged by 208 bps to 15.85% in 2024, then increased by 9 bps to 17.34% in 2025, then gained by 22 bps to 21.14% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 21.14%, 19.16%, and 17.34% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -12.95% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -7.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 21.14% |
| Mar 29, 2026 | 19.16% |
| Dec 28, 2025 | 17.34% |
| Sep 28, 2025 | 20.94% |
| Jun 29, 2025 | 20.21% |
| Mar 30, 2025 | 15.75% |
| Dec 29, 2024 | 15.85% |
| Sep 29, 2024 | 68.61% |
| Jun 30, 2024 | -147.21% |
| Mar 31, 2024 | -10.32% |
| Dec 31, 2023 | -14.62% |
| Oct 1, 2023 | -67.38% |
| Jul 2, 2023 | -7.48% |
| Apr 2, 2023 | -5.89% |
| Jan 1, 2023 | -319.41% |
| Oct 2, 2022 | -327.98% |
| Jul 3, 2022 | -49.83% |
| Apr 3, 2022 | 15.04% |
| Oct 3, 2021 | -49.19% |
| Jul 4, 2021 | 16.61% |